Boston Children’s – HeartDefects

Boston Children’s – HeartDefects Video Post Thumb

Ghost Medical offers medical animation and VR services to showcase medical devices and pharmaceutical products, such as Boston Children’s Light-reflecting balloon catheter. Contact them to learn more.

Mid Aortic Syndrome | Boston Childrens Hospital 2018 Animation

Mid Aortic Syndrome Boston Childrens Hospital 2018 Animation Video Post Thumb

Discover how Boston Children’s Hospital is revolutionizing the treatment of mid aortic syndrome, a rare and serious condition affecting children and young adults. Ghost Medical Animation collaborated with Boston Children’s Hospital to create a visually compelling animation that introduces their groundbreaking surgical approaches.

Tissue Expander Stimulated Lengthening of Arteries ( Tesla )

Tissue Expander Stimulated Lengthening of Arteries ( Tesla ) Video Post Thumb

Learn about the Tesla Procedure at Boston Children’s Hospital, a revolutionary approach to treat mid aortic syndrome in children and young adults. Ghost Medical Animation presents a visually compelling animation that showcases this life-changing medical advancement.

AltaValve™ Supra-Annular (TMVR) | 4C Medical

AltaValve™ Supra-Annular (TMVR) 4C Medical Video Post Thumb

4C Medical’s AltaValve™ Supra-Annular Transcatheter Mitral Valve Replacement (TMVR) is a cutting-edge medical device specifically designed to treat mitral valve regurgitation. This advanced device offers a minimally invasive alternative to traditional open-heart surgery, which can be risky and require a long recovery time.

Tendyne™ Transcatheter Mitral Valve Replacement (TMVR)

Tendyne™ Transcatheter Mitral Valve Replacement (TMVR) Video Post Thumb

Explore the groundbreaking Tendyne™ Transcatheter Mitral Valve Replacement device in this captivating animation by Ghost Medical Animation. Abbott, a pioneer in diagnostics, medical devices, nutrition, and pharmaceuticals, presents this revolutionary TMVR option for patients with symptomatic, significant MR (≥ grade 3).